TTi Health Research & Economics

If you or someone you know is looking for a clinical research contract opportunity, please apply or pass along! https://lnkd.in/eeYnYJHR

?? As you prepare to showcase your groundbreaking innovation, it's crucial to focus on the final steps: publication and dissemination. Here’s why this final step is essential for maximizing your impact: ?? Showcase Positive Patient Outcomes Publishing your results allows you to clearly demonstrate the direct benefits your innovation has brought to patients. This visibility is key for building trust among healthcare professionals and patients alike. Additionally, presenting positive outcomes helps differentiate your solution in a competitive market, affirming its effectiveness and safety. ?? Demonstrate Cost-Effectiveness Detailed publication of cost-effectiveness data provides a compelling argument for your innovation’s financial viability. This evidence is crucial for persuading payers and providers to adopt your solution, as it showcases the potential for significant cost savings and resource optimization. Highlighting these aspects can facilitate quicker adoption and broader market acceptance. ?? Build Credibility and Trust A rigorous and transparent study enhances your reputation within the medtech community and establishes your innovation as a credible solution. Peer-reviewed publications and well-disseminated research contribute to a stronger professional standing and open doors for future collaborations. A solid track record of published research also attracts attention from potential investors and partners. ??? Engage with Stakeholders Effective dissemination ensures that your findings reach key stakeholders who can advocate for your innovation. Engaging with these influencers through presentations, conferences, and targeted communications helps build strong relationships and fosters industry support. This engagement is crucial for gaining endorsements and expanding your network. ?? Expand Market Reach Publishing your research increases your innovation’s visibility across the global market, setting the stage for broader adoption. It also attracts attention from international markets and potential global partners, amplifying your reach and impact. Strategic dissemination can open new opportunities for scaling your solution and driving worldwide success. We understand the critical role of this final phase and are dedicated to helping you craft a compelling narrative that highlights your innovation's value. Our expertise can guide you through the process, ensuring your findings make a powerful impact. This concludes our 10-part strategic clinical studies series. Schedule a chat: discuss your innovation with our VP of Client Relations, Fernanda Nusbaum https://lnkd.in/eT8Ngyn9 TTi's newsletter: Sign up and share! https://lnkd.in/ezh2PSX2 #MedTech #CRO #LitReview #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics #LitReview #Presentation #Value

Proper study closure is essential for a successful clinical research process. Here’s how we manage this critical phase: ?? Study Closure: We ensure all study activities are completed and properly documented. Our strategic approach includes thorough checks and detailed documentation, unlike the more basic procedures often used by average CROs. We also provide a comprehensive final review to ensure completeness. ?? Final Report: We prepare a comprehensive final report summarizing study findings. Our strategic team provides detailed and insightful reporting tailored to your needs, unlike the standard reports provided by average CROs. We also assist with the presentation of results to stakeholders. With our team’s expertise in study closure and final reporting, you can be confident in the thoroughness and quality of your study's conclusion. Our final strategic clinical studies segment will cover publication and dissemination. Schedule a chat: discuss your innovation with our VP of Client Relations, Fernanda Nusbaum https://lnkd.in/eT8Ngyn9 TTi's newsletter: Sign up and share! https://lnkd.in/ezh2PSX2 #MedTech #CRO #LitReview #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics #LitReview #Presentation #Value

Post-market surveillance is essential for ongoing device evaluation. Here’s how we support you even after your study: ?? Post-Market Studies: We design and conduct post-market studies to gather additional data on device performance. Our strategic team customizes post-market strategies to address specific post-launch needs, unlike the generic approaches of average CROs. We also provide actionable insights to guide future improvements. ?? Ongoing Monitoring: We provide continuous monitoring to ensure ongoing safety and effectiveness. Our proactive approach offers more detailed and timely insights than average CROs, who may provide less frequent updates. We also address any emerging issues quickly to ensure device safety. Our expertise in post-market surveillance ensures your device’s ongoing success and compliance with regulatory standards. Part 9/10 of our strategic clinical studies series will be about successful study closeout. Schedule a chat: discuss your innovation with our VP of Client Relations, Fernanda Nusbaum https://lnkd.in/eT8Ngyn9 TTi's newsletter: Sign up and share! https://lnkd.in/ezh2PSX2 #MedTech #CRO #LitReview #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics #LitReview #Presentation #Value

Accurate data analysis and reporting are crucial for interpreting study results. Here’s how we excel in this final phase: ?? Data Management: We ensure data is accurately collected, verified, and entered into our systems. Our strategic team employs advanced data management techniques to ensure accuracy and reliability, unlike average CROs with standard practices. We also conduct thorough data validation to prevent errors. ?? Statistical Analysis: We perform detailed statistical analysis based on your study’s plan. Our approach provides deeper insights and more robust interpretations compared to the basic analyses often provided by average CROs. We also offer expert consultations to interpret complex results. ?? Clinical Study Report: We prepare comprehensive reports detailing study findings. Unlike average CROs who might offer generic reports, our strategic team customizes reports to highlight key insights and meet regulatory requirements. We also ensure the report is clear and accessible for all stakeholders. With our team’s in-depth expertise in data analysis and reporting, we deliver high-quality results and valuable insights for your clinical study. Next time we’ll cover market success (8/10)! Schedule a chat: discuss your innovation with our VP of Client Relations, Fernanda Nusbaum https://lnkd.in/eT8Ngyn9 TTi's newsletter: Sign up and share! https://lnkd.in/ezh2PSX2 #MedTech #CRO #LitReview #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics #LitReview #Presentation #Value

Managing and monitoring study data is crucial for ensuring accuracy and compliance. Here’s how we excel in this phase: ?? Patient Recruitment: We implement targeted strategies to efficiently recruit and enroll participants. Our strategic team uses advanced recruitment methods tailored to your study’s needs, unlike average CROs with more generic approaches. We also provide regular updates on recruitment progress. ?? Data Collection: We ensure meticulous data collection and management in line with the study protocol. Our strategic team provides rigorous oversight to maintain data integrity, distinguishing us from average CROs who may lack this level of detail. We also employ cutting-edge technology to enhance data accuracy. ?? Site Monitoring: We regularly monitor sites to ensure compliance and address issues promptly. Our proactive monitoring approach ensures adherence to protocols, while average CROs may only provide reactive support. We also conduct periodic audits to ensure high standards are maintained. Our team’s advanced data management expertise ensures the highest quality and reliability of your study results. Our next strategic clinical studies content (7/10) is all about synthesizing data findings. Schedule a chat: discuss your innovation with our VP of Client Relations, Fernanda Nusbaum https://lnkd.in/eT8Ngyn9 TTi's newsletter: Sign up and share! https://lnkd.in/ezh2PSX2 #MedTech #CRO #LitReview #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics #LitReview #Presentation #Value

??? In Just Two Days? Our President & CEO, April Zambelli-Weiner, Ph.D., will be speaking at Austin MedTech Connect's Focus on the Founder event on Wednesday, October 23, from 5:00 PM to 9:00 PM CDT at Capital Factory in Austin, Texas. ?? Registration & More Info: https://lu.ma/ncy5efqo Also an instructor, mentor, & research scientist at The Johns Hopkins Center for Bioengineering Innovation & Design, April will share her expertise as a senior healthcare leader, innovator, and entrepreneur. With her experience in launching and growing hundreds of products across diverse indication areas, attendees can expect valuable commercialization and research insights. ?? Joining her will be our VP of Client Relations, Fernanda Nusbaum, who will be there to connect and engage with everyone. ? We're thankful for this great opportunity to learn from other industry leaders and network with MedTech founders! Here's a little bit about what we do. ?? #LifeSciencesSummit #HealthTech #MedTech #AustinMedTechSummit

As the AdvaMed conference begins, we want to highlight the advantages of our integrated approach to medical affairs, clinical research, & market access. ??Holistic Solutions: Unlike traditional CROs that operate in silos, our team offers a unified approach delivers comprehensive solutions tailored to your specific needs. We recently helped a client streamline their clinical trial processes while enhancing their market access strategy, resulting in a 30% reduction in time to market. This holistic strategy ensures that every element of your research is aligned with your strategic objectives, enhancing overall project success. ??Collaborative Team: Our multidisciplinary team works to provide integrated solutions & prioritize alignment with your broader business goals, drawing on insights from medical affairs, clinical research, & market access. We recently helped integrate a client’s existing market access data into their clinical study design, which significantly improved stakeholder buy-in and facilitated a smoother product launch. This approach ensures that your strategies effectively support adoption, value analysis, & implementation, addressing all research needs. ??Strategic Integration: Our multidisciplinary expertise offers a strategic advantage that traditional CROs cannot match. Our integrated approach enables us to tackle adoption barriers and enhance market access effectively, drawing from our team's extensive experience in each discipline. Recently, we collaborated with a biotech firm to optimize their product's value proposition, which not only improved reimbursement outcomes but also strengthened their engagement with key opinion leaders at the same time. We provide the comprehensive support you need to drive successful outcomes and hitting your goals. ??Proven Track Record: Our commitment to excellence is demonstrated through our successful partnerships and tangible outcomes. By leveraging our deep industry knowledge and data analytics capabilities, we ensure that our clients can navigate complex regulatory environments and achieve their desired outcomes efficiently. This experience underscores our dedication to driving impactful results in every facet of medical affairs, clinical research, and market access. We're looking forward to meeting everyone in Toronto! We're excited to discuss how our integrated expertise can support your projects. ?? Not sure if you're going to make it to the AdvaMed conference? Either way, schedule a time to chat with April and Fernanda via this link or reach out via email. https://lnkd.in/ePPJX-yn ?? Share TTi's newsletter with your team. https://lnkd.in/eutCmYBW #MedTechCon #MTC24 #MedTech #CRO #LitReview #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics #LitReview #Presentation #Value #Cancer #CVD #Risk #Ethics

As we gear up for the AdvaMed MedTech Conference, we want to highlight our commitment to ethics and de-risking your MedTech studies. At TTi, we understand that effective research requires a streamlined approach tailored to your specific needs. ??Ethical Standards: We uphold the highest ethical standards across all our studies. Our dedicated team of compliance officers and research scientists ensures transparency, integrity, and compliance - crucial for the credibility and validity of your research. This rigorous approach guarantees that your studies adhere to the highest ethical benchmarks, fostering trust and reliability. ??Risk Management: Our de-risking strategies encompass thorough risk assessments and proactive mitigation plans. Our specialists conduct detailed analyses to identify potential issues and implement strategies to address them before they affect your research. This proactive approach minimizes uncertainties and enhances the reliability of your studies, giving you confidence in the robustness of your findings. ??No Wasted Resources at AdvaMed: You won’t see us spending on an extravagant booth at the conference. Instead, we’ll be on the ground, actively networking and enhancing our current MedTech relationships. This focused presence ensures we remain available to support your work without incurring unnecessary costs and passing them on to you. ??Reliable Outcomes: By partnering with us, you benefit from our commitment to producing reliable, actionable results. Our team’s expertise in methodological rigor and ethical practices ensures that your research outcomes are dependable and support your strategic objectives. We focus on delivering high-quality results that you can trust for informed decision-making and successful project outcomes. ?? Not sure if you're going to make it to the AdvaMed conference? Either way, schedule a time to chat with April and Fernanda via this link or reach out via email. https://lnkd.in/ePPJX-yn ?? Share TTi's newsletter with your team. https://lnkd.in/eutCmYBW #MedTechCon #MTC24 #MedTech #CRO #LitReview #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics #LitReview #Presentation #Value #Cancer #CVD #Risk #Ethics

With the AdvaMed Conference just days away, we’re excited to highlight how our expertise in digital health & AI can transform your research projects: ?? User Playbook Development: We created a comprehensive user playbooks that include cost, outcomes, programmatic data, and accounts for heterogeneity across various data sources. This allows healthcare payors and larger employers to evaluate the ROI and impact of your technology - for example, an mHealth-based behavioral counseling program, which is essential for managing chronic conditions often encountered in surgical patients. ??Phased Evidence Generation Programs: For a technology using traditional scanners to create 4-dimensional images of the lungs, we developed an evidence generation program and revenue roadmap aimed at improving COPD diagnosis utilizing our capability in the surgical and respiratory fields. ??Health Economic Models: We have designed HE models for adaptive radiotherapy planning technology, showcasing our ability to integrate advanced AI into surgical applications effectively. Our payer perspective HE models can also inform the development of key value drivers for mHealth and other applications, ensuring that your technology aligns with market needs. ??Facility Perspective HE Models: Our facility perspective HE models help develop key value drivers for hospitals - such as for digital therapeutics in oncology practices compared to standard care. . ??Clinical Dossier Development: We've developed a clinical dossiers for numerous technologies, including a complex, integrated arrhythmia diagnostic system that includes a deep-learning algorithm capable of identifying 12 cardiac rhythms when paired with long-term external monitoring—illustrating our expertise in advanced diagnostic technologies. ??Reimbursement Landscapes: We have assessed the baseline reimbursement landscape for our clients, including mobile health apps and wearables, and conducted analyses for mobile health applications intended to improve outcomes in hypertension. Our market sizing efforts also extend to wearables for heart failure management, providing you with comprehensive insights. ??Clinical Study Design: Our experience in clinical study design and facility perspective HE analysis ensures that your research initiatives are strategically positioned for success in both the surgical and broader healthcare markets. ?? Not sure if you're going to make it to the AdvaMed conference? Either way, schedule a time to chat with April and Fernanda via this link or reach out via email. https://lnkd.in/ePPJX-yn ?? Share TTi's newsletter with your team. https://lnkd.in/eutCmYBW #MedTechCon #MTC24 #MedTech #CRO #LitReview #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics #LitReview #Presentation #Value #DigitalHealth #AI #Surgery #Surgical